secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001819790-24-000087
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus Pharma annual meeting elects two Class I directors, ratifies Ernst & Young auditor
--------------------------------------------------------------------------------

- Bhaskar Chaudhuri (21.8M for, 2.9M withheld) and William Link (20.8M for, 3.9M withheld) elected as Class I directors.
- Ratification of Ernst & Young as auditor for FY2024: 31.9M for, 24.9K against, 57.3K abstain.
- Total shares voted: 31,978,938 out of 37,776,665 outstanding, quorum achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979024000087/0001819790-24-000087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979024000087/tars-20240613.htm
  HTML page:      https://secwatch.observer/filing/0001819790-24-000087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer